Teruna J. Siahaan

Dr. Siahaan joined KU's Department of Pharmaceutical Chemistry in 2006, where he also serves as Associate Chair. From 2009-2019 he served as the Program Director of KU's T32 NIH Biotechnology Training Program, which trains pre-doctoral students to work in the development of therapeutic agents and vaccines such as peptides, proteins and oligonucleotides derived from biotechnology research. 

Dr. Siahaan's research interests are in the utilization and modulation of cell adhesion molecules on the cell surface for enhancing drug permeation through the intestinal mucosa and blood-brain barrier (BBB) and for targeted drug delivery to a specific immune cell type for controlling autoimmune diseases. His research group is also using peptides derived from cell adhesion molecules (i.e., ICAM-1 and LFA-1) to target drugs to leukocytes and vascular endothelial cells in inflammatory and autoimmune diseases (i.e., multiple sclerosis, type-1 diabetes, and rheumatoid arthritis). 

He is a fellow of the American Association of Pharmaceutical Scientists (AAPS).

Learn more about Teruna Siahaan on KU's Dept. of Pharmaceutical Chemistry website.